FDA·Medicines·September 9, 2026

Bionpharma recalls doxylamine succinate and pyridoxine tablets over foreign tablets or capsules found in bottles

The notice says the 100-count bottles of these delayed-release tablets may contain foreign tablets or capsules, meaning some bottles may hold pills that are not the medicine on the label.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20.
Hazard
Presence of Foreign Tablets/Capsules
Units
14,232 bottles (1,423,200 tablets)
Where sold
US Nationwide.
FDA classification
Class III · Ongoing
Classified by FDA
August 28, 2026
Recall started
August 7, 2026
FDA enforcement report
September 9, 2026
Identifiers
  • Codes: Lot # DMA25006, Exp Date: 11/30/2028.
  • FDA recall number: D-0822-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20.
Reason for recall
Presence of Foreign Tablets/Capsules
Classification
Class III (Ongoing)
Distribution
US Nationwide.
Quantity
14,232 bottles (1,423,200 tablets)

Related recalls